The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog is intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Support this site

    If you found the information here helpful, please consider supporting this site.If you found the information here helpful, please consider supporting this site.

  • Recent Posts

  • Recent Comments

    Does vitamin D reduce progression of knee osteoarthritis?

    During the American College of Rheumatology Annual Scientific Meeting, researchers in Boston reported (abstract 706) that adding vitamin D as a supplement did not lessen the symptoms or slow the progression of knee osteoarthritis.

    First, the details.

    • 94 patients with symptomatic knee osteoarthritis were divided into 2 treatment groups.
      • Vitamin D 2,000 IU of vitamin D daily, which was raised as necessary in 2,000 IU increments to help each participant achieve a vitamin D level higher than 30 ng/mL
      • Placebo
    • Hand x-rays were obtained at the start of the study and at 2 years.
    • Physical function tests were conducted.
    • Knee cartilage volume and thickness, and bone marrow lesion volume were measured.

    And, the results.

    • The average vitamin D level at the start of the study was  22 ngmL.
    • Patients in the vitamin D group had an average increased in vitamin D levels of 15 ng/mL vs 2 ng/mL with placebo.
    • There were no substantial differences between the groups in the parameters measured.

    The bottom line?

    Observational epidemiologic studies suggest that vitamin D may reduce the structural progression of knee osteoarthritis.

    The difference between those studies and this one might be related to the study design. The observational studies weren’t intended to compare the effects of vitamin D treatment to placebo.

    It’s also possible that vitamin D levels achieved (average 37 ng/mL) weren’t high enough to exert a therapeutic effect.

    11/11/10 21:20 JR

    Leave a Comment

    You must be logged in to post a comment.